• About
• Links
• Contact
• Sitemap
• 

The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

Summary

The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global respiratory diseases therapeutics market. The report analyzes the markets for respiratory disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis.

Scope

The scope of this report includes:

Annualized market data for the respiratory diseases therapeutics market from 2000 to 2008, forecast forward to 2015

Analysis of the leading therapeutic segments including asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension and cystic fibrosis

Analysis of the respiratory diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan

Market characterization of the respiratory diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns

Key drivers and barriers that have a significant impact on the market

Coverage of pipeline molecules in various phases of drug development

Competitive benchmarking of leading companies. The key companies studied in this report are Novartis AG, AstraZeneca and Merck & Co

Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global respiratory diseases therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to

Align product portfolio to the markets with high growth potential

Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth

Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety

Develop key strategic initiatives by understanding key focus areas of leading companies

Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Table of Contents

1 Table of Contents 4

• 1.1 List of Tables 6
• 1.2 List of Figures 9

2 Global Respiratory Therapeutics Market : Scope of Research 11

• 2.1 Introduction 11
• 2.2 Report Guidance 11

3 Global Respiratory Therapeutics Market : Market Characteraization 12

• 3.1 Market Forecasts 12
• 3.2 Branded Vs Generics 13
• 3.3 Average Cost of Therapy 14
• 3.4 Volume 15
• 3.5 Usage Patterns 16
  • 3.5.1 Diseased Population 16
  • 3.5.2 Treatment Seeking Population 17
  • 3.5.3 Diagnosed Population 18
  • 3.5.4 Prescription Population 19
  • 3.5.5 Usage Patterns 20
  • 3.5.6 Global Revenue Distribution Indication Wise 22

4 Global Asthma Therapeutics Market 23

• 4.1 Market Forecasts 23
• 4.2 Average Cost of Therapy 24
• 4.3 Volume 25
• 4.4 Usage Patterns 26
  • 4.4.1 Diseased Population 26
  • 4.4.2 Treatment Seeking Population 27
  • 4.4.3 Diagnosed Population 28
  • 4.4.4 Prescription Population 28
  • 4.4.5 Usage Patterns 29

5 Global COPD Therapeutics Market 31

• 5.1 Market Forecasts 31
• 5.2 Average Cost of Therapy 32
• 5.3 Volume 32
• 5.4 Usage Patterns 34
  • 5.4.1 Diseased Population 34
  • 5.4.2 Treatment Seeking Population 35
  • 5.4.3 Diagnosed Population 36
  • 5.4.4 Prescription Population 37
  • 5.4.5 Usage Patterns 37

6 Global Pulmonary Arterial Hypertension Therapeutics Market 39

• 6.1 Market Forecasts 39
• 6.2 Volume 40
• 6.3 Average Cost of Therapy 41
• 6.4 Usage Patterns 42
  • 6.4.1 Diseased Population 42
  • 6.4.2 Treatment Seeking Population 43
  • 6.4.3 Diagnosed Population 44
  • 6.4.4 Prescription Population 45
  • 6.4.5 Usage Patterns 45

7 Global Cystic Fibrosis Therapeutics Market 47

• 7.1 Market Forecasts 47
• 7.2 Volume 48
• 7.3 Average Cost of Therapy 49
• 7.4 Usage Patterns 50
  • 7.4.1 Diseased Population 50
  • 7.4.2 Treatment Seeking Population 51
  • 7.4.3 Diagnosed Population 52
  • 7.4.4 Prescription Population 53
  • 7.4.5 Usage Patterns 53

8 Global Respiratory Therapeutics Market : Market Drivers and Restraints 55

• 8.1 Market Drivers 55
  • 8.1.1 Steady Increase in the Smoking Population 55
  • 8.1.2 Stable Increase in Incidence Rates for Respiratory Diseases Disorders 56
  • 8.1.3 Increase in Awareness Levels of Disease Progression and Etiology 56
• 8.2 Market Restraints 56
  • 8.2.1 Patent Expirations and Entry of Generics Pose a Serious Problem for Primary Manufacturers 56
  • 8.2.2 Reimbursement Restrictions on Drug Classes for Certain Respiratory Diseases Drug Classes Restricts the Market Growth 57
• 8.3 Global Respiratory Therapeutics Market : Unmet Needs 57
• 8.4 Global Respiratory Therapeutics Market: Key Market Trends 58
• 8.5 Increase in Disease Incidence and Prevalence Rates 59
• 8.6 Product Pipeline 59
• 8.7 Advertising and Commercialization 59
• 8.8 Regulatory Trends – Current Reimbursement Scenario 59
  • 8.8.1 The Budget Impact on Drug Reimbursements 60
  • 8.8.2 Reliability on Generic Formulations as a Cost Cutting Measure 60

9 Global Respiratory Therapeutics Market: Competitive Landscape 61

• 9.1 Overview 61
• 9.2 Market Share Analysis 61
• 9.3 Competitive Profiling 62
  • 9.3.1 GlaxoSmithKline 63
  • 9.3.2 AstraZeneca 63
  • 9.3.3 Merck 63
  • 9.3.4 Boehringer Ingelheim GmbH 64

10 Global Respiratory Therapeutics Market : Strategic Consolidations 65

• 10.1 Mergers and Acquisitions 65
  • 10.1.1 Overview 65
• 10.2 Licensing Agreements 67
  • 10.2.1 Approval 69
  • 10.2.2 Filed 70
  • 10.2.3 Phase III 70
  • 10.2.4 Phase II 71
  • 10.2.5 Pre-clinical 72
  • 10.2.6 Discovery 72

11 Global Respiratory Therapeutics Market : Appendix 73

• 11.1 Market Definitions 73
• 11.2 Abbreviations 73
• 11.3 Research Methodology 74
  • 11.3.1 Coverage 74
  • 11.3.2 Primary Research 77
  • 11.3.3 Expert Panels 78
• 11.4 Contact Us 78
• 11.5 Disclaimer 78

1.1 List of Tables

• Table 1: Global Respiratory Therapeutics Market, Historical Revenues ($m), 2000-2008 12
• Table 2: Global Respiratory Therapeutics Market, Revenue Forecasts ($m), 2008-2015 12
• Table 3: Global Respiratory Therapeutics Market, Revenue ($bn) Segmentation, 2000-2008 13
• Table 4: Global Respiratory Therapeutics Market, Revenue ($bn) Segmentation, 2008-2015 14
• Table 5: Global Respiratory Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 14
• Table 6: Global Respiratory Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 15
• Table 7: Global Respiratory Therapeutics Market, Historical Figures for Volume, 2000-2008 15
• Table 8: Global Respiratory Therapeutics Market, Forecasts for Volume, 2008-2015 16
• Table 9: Global Respiratory Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 17
• Table 10: Global Respiratory Therapeutics Market, Forecasts for Diseased Population, 2008-2015 17
• Table 11: Global Respiratory Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 18
• Table 12: Global Respiratory Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 18
• Table 13: Global Respiratory Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008 19
• Table 14: Global Respiratory Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015 19
• Table 15: Global Respiratory Therapeutics Market, Historical Figures for Prescription Population, 2000-2008, 20
• Table 16: Global Respiratory Therapeutics Market, Forecasts for Prescription Population, 2008-2015 20
• Table 17: Global Respiratory Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 21
• Table 18: Global Respiratory Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 21
• Table 19: Global Asthma Therapeutics Market, Historical Revenues ($bn), 2000-2008 23
• Table 20: Global Asthma Therapeutics Market, Revenue Forecasts ($bn), 2008-2015 23
• Table 21: Global Asthma Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 24
• Table 22: Global Asthma Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015 24
• Table 23: Global Asthma Therapeutics Market, Historical Figures for Volume, 2000-2008 25
• Table 24: Global Asthma Therapeutics Market, Forecasts for Volume, 2008-2015 25
• Table 25: Global Asthma Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 26
• Table 26: Global Asthma Therapeutics Market, Forecasts for Diseased Population, 2008-2015 26
• Table 27: Global Asthma Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 27
• Table 28: Global Asthma Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 27
• Table 29: Global Asthma Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008 28
• Table 30: Global Asthma Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015 28
• Table 31: Global Asthma Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 29
• Table 32: Global Asthma Therapeutics Market, Forecasts for Prescription Population, 2008-2015 29
• Table 33: Global Asthma Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 30
• Table 34: Global Asthma Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 30
• Table 35: Global COPD Therapeutics Market, Historical Revenues ($m), 2000-2008 31
• Table 36: Global COPD Therapeutics Market, Revenue Forecasts ($m), 2008-2015 31
• Table 37: Global COPD Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008 32
• Table 38: Global COPD Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015 32
• Table 39: Global COPD Therapeutics Market, Historical Figures for Volume, 2000-2008 33
• Table 40: Global COPD Therapeutics Market, Forecasts for Volume, 2008-2015 33
• Table 41: Global COPD Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 34
• Table 42: Global COPD Therapeutics Market, Forecasts for Diseased Population, 2008-2015 34
• Table 43: Global COPD Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 35
• Table 44: Global COPD Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 35
• Table 45: Global COPD Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008 36
• Table 46: Global COPD Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015 36
• Table 47: Global COPD Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 37
• Table 48: Global COPD Therapeutics Market, Forecasts for Prescription Population, 2008-2015 37
• Table 49: Global COPD Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 38
• Table 50: Global COPD Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 38
• Table 51: Global Pulmonary Hypertension Therapeutics Market, Historical Revenues ($m), 2000-2008 39
• Table 52: Global Pulmonary Hypertension Therapeutics Market, Revenue Forecasts ($m), 2008-2015 39
• Table 53: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Volume, 2000-2008 40
• Table 54: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Volume, 2008-2015 40
• Table 55: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 41
• Table 56: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 41
• Table 57: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 42
• Table 58: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diseased Population, 2008-2015 42
• Table 59: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 43
• Table 60: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 43
• Table 61: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008 44
• Table 62: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015 44
• Table 63: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 45
• Table 64: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Prescription Population, 2008-2015 45
• Table 65: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 46
• Table 66: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 46
• Table 67: Global Cystic Fibrosis Therapeutics Market, Historical Revenues ($m), 2000-2008 47
• Table 68: Global Cystic Fibrosis Therapeutics Market, Revenue Forecasts ($m), 2008-2015 47
• Table 69: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Volume, 2000-2008 48
• Table 70: Global Cystic Fibrosis Therapeutics Market, Forecasts for Volume, 2008-2015 48
• Table 71: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 49
• Table 72: Global Cystic Fibrosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 49
• Table 73: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 50
• Table 74: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diseased Population, 2008-2015 50
• Table 75: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 51
• Table 76: Global Cystic Fibrosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 51
• Table 77: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008 52
• Table 78: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015 52
• Table 79: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 53
• Table 80: Global Cystic Fibrosis Therapeutics Market, Forecasts for Prescription Population, 2008-2015 53
• Table 81: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008 54
• Table 82: Global Cystic Fibrosis Therapeutics Market, Forecasts for Usage Patterns, 2008-2015 54
• Table 83: Global Respiratory Therapeutics Market, Market Drivers, 2008 55
• Table 84: Global Respiratory Therapeutics Market, Market Restraints, 2008 56
• Table 85: Global Respiratory Therapeutics Market, Major Drug Patent Expirations, 2008-2015 57
• Table 86: Global Respiratory Therapeutics Market, Licensing Agreements for Approved Drugs, 2008-2009 69
• Table 87: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the NDA/BLA Filed Stage, 2008-2009 70
• Table 88: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Phase III Stage, 2008-2009 71
• Table 89: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Phase II Stage, 2008-2009 71
• Table 90: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Pre-Clinical Stage, 2008-2009 72
• Table 91: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Discovery Stage, 2008-2009 72

1.2 List of Figures

• Figure 1: Global Respiratory Therapeutics Market, Revenue Forecasts ($m), 2000-2015 12
• Figure 2: Global Respiratory Therapeutics Market, Revenue Segmentation, 2000-2015 13
• Figure 3: Global Respiratory Therapeutics Market, Average Cost of Therapy ($), 2000-2015 14
• Figure 4: Global Respiratory Therapeutics Market, Volume, 2000-2015 15
• Figure 5: Global Respiratory Therapeutics Market, Diseased Population, 2000-2015 16
• Figure 6: Global Respiratory Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 17
• Figure 7: Global Respiratory Therapeutics Market, Global Forecasts for Diagnosed Population, 2000-2015 19
• Figure 8: Global Respiratory Therapeutics Market, Forecasts for Prescription Population, 2000-2015 20
• Figure 9: Global Respiratory Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 21
• Figure 10: Global Respiratory Therapeutics Market, , Revenue Distribution Indication Wise ($m), 2000-2015 22
• Figure 11: Global Asthma Therapeutics Market, Revenue Forecasts ($m), 2000-2015 23
• Figure 12: Global Asthma Therapeutics Market, Average Cost of Therapy ($), 2000-2015 24
• Figure 13: Global Asthma Therapeutics Market, Volume, 2000-2015 25
• Figure 14: Global Asthma Therapeutics Market, Forecasts for Diseased Population, 2000-2015 26
• Figure 15: Global Asthma Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 27
• Figure 16: Global Asthma Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015 28
• Figure 17: Global Asthma Therapeutics Market, Forecasts for Prescription Population, 2000-2015 29
• Figure 18: Global Asthma Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 30
• Figure 19: Global COPD Therapeutics Market, Revenue Forecasts ($m), 2000-2015 31
• Figure 20: Global COPD Therapeutics Market, Average Cost of Therapy ($), 2000-2015 32
• Figure 21: Global COPD Therapeutics Market, Volume, 2000-2015 33
• Figure 22: Global COPD Therapeutics Market, Forecasts for Diseased Population, 2000-2015 34
• Figure 23: Global COPD Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 35
• Figure 24: Global COPD Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015 36
• Figure 25: Global COPD Therapeutics Market, Forecasts for Prescription Population, 2000-2015 37
• Figure 26: Global COPD Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 38
• Figure 27: Global Pulmonary Hypertension Therapeutics Market, Revenue Forecasts ($m), 2000-2015 39
• Figure 28: Global Pulmonary Hypertension Therapeutics Market, Volume, 2000-2015 40
• Figure 29: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015 41
• Figure 30: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diseased Population, 2000-2015 42
• Figure 31: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 43
• Figure 32: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015 44
• Figure 33: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Prescription Population, 2000-2015 45
• Figure 34: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 46
• Figure 35: Global Cystic Fibrosis Therapeutics Market, Revenue Forecasts ($m), 2000-2015 47
• Figure 36: Global Cystic Fibrosis Therapeutics Market, Volume, 2000-2015 48
• Figure 37: Global Cystic Fibrosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015 49
• Figure 38: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diseased Population, 2000-2015 50
• Figure 39: Global Cystic Fibrosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015 51
• Figure 40: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015 52
• Figure 41: Global Cystic Fibrosis Therapeutics Market, Forecasts for Prescription Population, 2000-2015 53
• Figure 42: Global Cystic Fibrosis Therapeutics Market, Forecasts for Usage Patterns, 2000-2015 54
• Figure 43: Global Respiratory Therapeutics Market, Market Indicators, 2008 55
• Figure 44: Global Respiratory Therapeutics Market, Analysis of Unmet Needs for Major Disease Sectors, 2008 58
• Figure 45: Global Respiratory Therapeutics Market, Key Market Events, 2008-2015 58
• Figure 46: Global Respiratory Therapeutics Market, Market Share of Top Manufacturers, 2008 61
• Figure 47: Respiratory Therapeutics Market, Global Benchmarking Analysis for the Top Four Manufacturers, 2008 62
• Figure 48: Respiratory Therapeutics Market, Global Benchmarking Analysis for the Top Four Manufacturers, Pipeline and Unmet Need Analysis, 2008 63
• Figure 49: Global Respiratory Therapeutics Market, M&A Deals by Geography, 2008 65
• Figure 50: Global Respiratory Therapeutics Market, M&A Deals by Deal Size, 2008 65
• Figure 51: Global Respiratory Therapeutics Market, M&A Deals by Phase, 2008 66
• Figure 52: Global Respiratory Therapeutics Market, Top Three M&A Deals, 2008 66
• Figure 53: Global Respiratory Therapeutics Market, Licensing Agreements by Geography, 2008 67
• Figure 54: Global Respiratory Therapeutics Market, Licensing Agreements by Deal Size, 2008 68
• Figure 55: Global Respiratory Therapeutics Market, Licensing Agreements by Phases of Development, 2008 68
• Figure 56: Global Respiratory Therapeutics Market, Licensing Agreements by Indications, 2008 69
• Figure 57: Research Methodology 74
• Figure 58: Research Market Forecasting Model 77

Other users found this report page using the following search terms: asthma chronic obstructive pulmonary disease COPD pulmonary hypertension PAH cystic fibrosis market respiratory asthma disease future size drugs therapeutics diseases cystic

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.

Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.